Senhwa Biosciences, Inc.

Senhwa Biosciences, Inc.verified

6492.TWO

Price:

$41.6

Market Cap:

$3.72B

Senhwa Biosciences, Inc., a drug development company, engages in the development of new drugs and targeted agents. The company develops CX-5461, a phase I, open-label, dose escalation, safety, pharmacokinetic, and pharmacodynamics study of intravenously administered CX-5461 in patients with advanced hematologic malignancies; CX-5461, which is in a phase I study for solid tumors; CX-5461 that is in a phase Ib expansion study of CX-5461 in patients with solid tumors and BRCA2 and /or PALB2 mutation; and CX-5461, which is in Phase I trial of pidnarulex and talazoparib in patients with metastatic castration resistant prostate cancer. It is also developing CX-4945-CCA that is in phase I/II clinic...[Read more]

Industry

Biotechnology

IPO Date

2014-12-04

Stock Exchange

TWO

Ticker

6492.TWO

The Current Ratio as of December 2025 (TTM) for Senhwa Biosciences, Inc. (6492.TWO) is 38.00

According to Senhwa Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 38.00. This represents a change of -0.81% compared to the average of 38.31 of the last 4 quarters.

Senhwa Biosciences, Inc. (6492.TWO) Historical Current Ratio (quarterly & annually)

How has 6492.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Senhwa Biosciences, Inc. over the last ten years is 32.69. The current 38.00 Current Ratio has changed 11.52% with respect to the historical average. Over the past ten years (40 quarters), 6492.TWO's Current Ratio was at its highest in in the March 2023 quarter at 97.75. The Current Ratio was at its lowest in in the December 2021 quarter at 24.87.

Quarterly (TTM)
Annual

Average

32.69

Median

31.40

Minimum

24.87

Maximum

49.69

Senhwa Biosciences, Inc. (6492.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Senhwa Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 99.85%

Maximum Annual Current Ratio = 49.69

Minimum Annual Increase = -36.82%

Minimum Annual Current Ratio = 24.87

Quarterly (TTM)
Annual
YearCurrent RatioChange
202433.296.02%
202331.40-36.82%
202249.6999.85%
202124.87-36.08%
202038.9034.29%
201928.97-14.62%
201833.9321.33%
201727.9610.72%

Senhwa Biosciences, Inc. (6492.TWO) Average Current Ratio

How has 6492.TWO Current Ratio performed in the past?

The current Current Ratio of Senhwa Biosciences, Inc. (6492.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

38.13

5-year avg

35.63

10-year avg

32.69

Senhwa Biosciences, Inc. (6492.TWO) Current Ratio vs. Peers

How is 6492.TWO’s Current Ratio compared to its peers?

Senhwa Biosciences, Inc.’s Current Ratio is greater than Formosa Pharmaceuticals, Inc. (9.57), greater than Energenesis Biomedical CO.,LTD. (34.47), greater than Medigen Biotechnology Corp. (5.12), greater than BRIM Biotechnology, Inc. (5.18), greater than AnnJi (4.99), greater than TWi Biotechnology, Inc. (2.78), greater than UnicoCell Biomed Co., Ltd. (35.10), greater than Orient EuroPharma Co., Ltd. (1.65), greater than Synbio Tech Inc. (1.46), greater than Syngen Biotech Co.,Ltd. (2.06),

Build a custom stock screener for Senhwa Biosciences, Inc. (6492.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Senhwa Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Senhwa Biosciences, Inc. (6492.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Senhwa Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Senhwa Biosciences, Inc.'s Current Ratio?

How is the Current Ratio calculated for Senhwa Biosciences, Inc. (6492.TWO)?

What is the highest Current Ratio for Senhwa Biosciences, Inc. (6492.TWO)?

What is the 3-year average Current Ratio for Senhwa Biosciences, Inc. (6492.TWO)?

What is the 5-year average Current Ratio for Senhwa Biosciences, Inc. (6492.TWO)?

How does the current Current Ratio for Senhwa Biosciences, Inc. (6492.TWO) compare to its historical average?